CLDN3 and type 2 diabetes mellitus: The current study is the first study to demonstrate the potent effects of dietary GEG supplementation on improving intestinal barrier function, as shown by increased Claudin-3 gene expression and immunofluorescence images in the colon of T2DM male rats.